A review of the genetic determinants of praziquantel resistance in Schistosoma mansoni: is praziquantel and intestinal schistosomiasis a perfect match?

Shannan Summers*, Tapan Bhattacharyya, Fiona Allan, J Russell Stothard, Andrew Edielu, Bonnie L. Webster, Michael A. Miles, Amaya L. Bustinduy

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)
9 Downloads (Pure)

Abstract

Schistosomiasis is a neglected tropical disease (NTD) caused by parasitic trematodes belonging to the Schistosoma genus. The mainstay of schistosomiasis control is the delivery of a single dose of praziquantel (PZQ) through mass drug administration (MDA) programs. These programs have been successful in reducing the prevalence and intensity of infections. Due to the success of MDA programs, the disease has recently been targeted for elimination as a public health problem in some endemic settings. The new World Health Organization (WHO) treatment guidelines aim to provide equitable access to PZQ for individuals above two years old in targeted areas. The scale up of MDA programs may heighten the drug selection pressures on Schistosoma parasites, which could lead to the emergence of PZQ resistant schistosomes. The reliance on a single drug to treat a disease of this magnitude is worrying should drug resistance develop. Therefore, there is a need to detect and track resistant schistosomes to counteract the threat of drug resistance to the WHO 2030 NTD roadmap targets. Until recently, drug resistance studies have been hindered by the lack of molecular markers associated with PZQ resistance. This review discusses recent significant advances in understanding the molecular basis of PZQ action in S. mansoni and proposes additional genetic determinants associated with PZQ resistance. PZQ resistance will also be analyzed in the context of alternative factors that may decrease efficacy within endemic field settings, and the most recent treatment guidelines recommended by the WHO.
Original languageEnglish
Article number933097
Number of pages12
JournalFrontiers in Tropical Diseases
Volume3
DOIs
Publication statusPublished - 22 Aug 2022

Keywords

  • Preventive chemotherapy
  • Praziquantel
  • Drug resistance
  • Drug tolerance
  • Blood flukes
  • Schistosomes
  • Schistosoma mansoni

Fingerprint

Dive into the research topics of 'A review of the genetic determinants of praziquantel resistance in Schistosoma mansoni: is praziquantel and intestinal schistosomiasis a perfect match?'. Together they form a unique fingerprint.

Cite this